title: Sodium binding to hH3R and hH 4R--a molecular modeling study.
abstract: Several aminergic GPCRs, e.g., the human histamine H3-receptor (hH3R) are sensitive to sodium ions. Based on these experimental results, including site directed mutagenesis studies, a sodium binding pocket near to the highly conserved Asp2.50 was suggested. Recently, in the crystallized adenosine A2A receptor (4EIY), a sodium ion was found in a pocket, coordinated by Asp52, Ser91, and three water molecules. Despite high homology in amino acid sequence between hH3R and hH4R, pharmacological studies revealed that the hH4R is--in contrast to hH3R--not sensitive to sodium ions. In order to obtain a deeper insight onto the differences in sodium sensitivity between hH3R and hH4R, we performed molecular modelling studies, including molecular dynamic simulations and calculation of Gibbs energy of solvation. The results of the modeling studies suggested that the amino acid at position 7.42 influences sodium binding to aminergic GPCRs in different ways. A comparison of the amino acids forming the sodium binding channel between the ligand binding pocket and the sodium binding pocket of all human aminergic GPCRs showed an 80% occurrence of glycine--in contrast to hH3R and hH4R. The Gln7.42 at hH4R disrupts a water chain, connecting the Asp3.32 of the orthosteric binding site and the Asp2.50 of the allosteric binding site. Besides, the oxygen of the glutamine side chain stabilizes the interaction of the sodium ion with the Asp3.32. Thus, the binding of the sodium into the allosteric binding site might be hindered kinetically.
authors.affiliation: Faculty of Chemistry and Pharmacy, University of Regensburg, Universitätsstraße 31, 93040, Regensburg, Germany.
authors.forename: Hans-Joachim
authors.initials: HJ
authors.lastname: Wittmann
authors.forename: Roland
authors.initials: R
authors.lastname: Seifert
authors.forename: Andrea
authors.initials: A
authors.lastname: Strasser
mesh_terms: D003545:Cysteine / Q000378:metabolism; D005110:Extracellular Space / Q000737:chemistry; D006801:Humans; D007477:Ions; D008958:Models, Molecular; D050505:Mutant Proteins / Q000737:chemistry / Q000378:metabolism; D011487:Protein Conformation; D043562:Receptors, G-Protein-Coupled / Q000737:chemistry / Q000378:metabolism*; D011968:Receptors, Histamine / Q000737:chemistry / Q000378:metabolism*; D018100:Receptors, Histamine H3 / Q000737:chemistry / Q000378:metabolism*; D000074040:Receptors, Histamine H4; D012964:Sodium / Q000378:metabolism*; D015222:Sodium Channels / Q000378:metabolism; D012997:Solvents / Q000737:chemistry; D055672:Static Electricity; D013816:Thermodynamics
chemical_list: C418607:HRH4 protein, human; D007477:Ions; D050505:Mutant Proteins; D043562:Receptors, G-Protein-Coupled; D011968:Receptors, Histamine; D018100:Receptors, Histamine H3; D000074040:Receptors, Histamine H4; D015222:Sodium Channels; D012997:Solvents; D012964:Sodium; D003545:Cysteine
references.citation: Mini Rev Med Chem. 2005 Jun;5(6):555-61
references.pmid: 15974933
references.citation: Angew Chem Int Ed Engl. 2013 Sep 16;52(38):10112-5
references.pmid: 23904331
references.citation: J Pharmacol Exp Ther. 2008 Sep;326(3):783-91
references.pmid: 18577700
references.citation: Expert Opin Investig Drugs. 2009 Oct;18(10):1519-31
references.pmid: 19758107
references.citation: ChemMedChem. 2006 Aug;1(8):761-82
references.pmid: 16902930
references.citation: J Pharmacol Exp Ther. 2009 Jan;328(1):40-54
references.pmid: 18849360
references.citation: PLoS Comput Biol. 2010 Aug 12;6(8):
references.pmid: 20711351
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 2014 Mar;387(3):235-50
references.pmid: 24241585
references.citation: Recept Channels. 2001;7(5):357-69
references.pmid: 11697079
references.citation: Biochem Pharmacol. 2009 Sep 15;78(6):607-16
references.pmid: 19464266
references.citation: Trends Pharmacol Sci. 2013 Jan;34(1):33-58
references.pmid: 23254267
references.citation: Trends Pharmacol Sci. 2013 Jan;34(1):13-32
references.pmid: 23228711
references.citation: Mol Pharmacol. 1991 Jun;39(6):733-9
references.pmid: 1828858
references.citation: Pharmacol Rev. 2005 Jun;57(2):279-88
references.pmid: 15914470
references.citation: Nature. 2011 Jun 22;475(7354):65-70
references.pmid: 21697825
references.citation: Drug Discov Today. 2002 Feb 15;7(4):235-46
references.pmid: 11839521
references.citation: Science. 2012 Jul 13;337(6091):232-6
references.pmid: 22798613
references.citation: In Silico Pharmacol. 2014 Dec;2(1):1
references.pmid: 27502620
references.citation: Neuropharmacology. 2003 May;44(6):773-86
references.pmid: 12681376
references.citation: J Mol Graph. 1996 Feb;14(1):33-8, 27-8
references.pmid: 8744570
references.citation: J Comput Chem. 2002 Apr 15;23(5):548-53
references.pmid: 11948581
references.citation: Proc Natl Acad Sci U S A. 2009 May 26;106(21):8555-60
references.pmid: 19433801
references.citation: Trends Pharmacol Sci. 2011 Apr;32(4):250-7
references.pmid: 21414671
references.citation: Trends Pharmacol Sci. 1992 Oct;13(10):376-80
references.pmid: 1329292
references.citation: J Pharmacol Exp Ther. 2001 Feb;296(2):359-63
references.pmid: 11160618
references.citation: J Mol Model. 2013 Oct;19(10):4443-57
references.pmid: 23925512
references.citation: Pharmacol Rev. 1997 Sep;49(3):253-78
references.pmid: 9311023
references.citation: Neurosci Lett. 2010 Mar 19;472(2):114-8
references.pmid: 20132865
references.citation: Trends Pharmacol Sci. 1995 Mar;16(3):89-97
references.pmid: 7540781
references.citation: Science. 2007 Nov 23;318(5854):1258-65
references.pmid: 17962520
references.citation: Mol Pharmacol. 1991 Apr;39(4):570-8
references.pmid: 2017157
references.citation: J Biol Chem. 1994 Nov 25;269(47):29557-64
references.pmid: 7961941
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 2011 Sep;384(3):287-99
references.pmid: 21800095
references.citation: Life Sci. 2003 Sep 19;73(18):2263-80
references.pmid: 12941430
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 2002 Nov;366(5):381-416
references.pmid: 12382069
references.citation: Mol Pharmacol. 1999 Feb;55(2):210-5
references.pmid: 9927610
references.citation: J Am Chem Soc. 2008 Jan 23;130(3):892-900
references.pmid: 18163620
references.citation: Nat Rev Drug Discov. 2008 Jan;7(1):41-53
references.pmid: 18172439
references.citation: Trends Pharmacol Sci. 1993 Aug;14(8):303-7
references.pmid: 8249148
references.citation: J Comput Chem. 2004 Oct;25(13):1656-76
references.pmid: 15264259